Similar articles for PMID: 17363613

Year	Number of Results
1955	1
1959	1
1982	1
1988	1
1992	1
1993	1
1995	1
1996	2
1997	1
1998	1
1999	10
2000	4
2001	7
2002	8
2003	11
2004	20
2005	22
2006	37
2007	28
2008	28
2009	15
2010	17
2011	13
2012	13
2013	6
2014	8
2015	4
2016	7
2017	4
2018	6
2019	1
2021	1
2022	2
2024	0

1

Low-level TOP2A amplification in prostate cancer is associated with HER2 duplication, androgen resistance, and decreased survival.

Murphy AJ, Hughes CA, Barrett C, Magee H, Loftus B, O'Leary JJ, Sheils O. Murphy AJ, et al. Cancer Res. 2007 Mar 15;67(6):2893-8. doi: 10.1158/0008-5472.CAN-06-2962. Cancer Res. 2007. PMID: 17363613

2

Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study.

Kanta SY, Yamane T, Dobashi Y, Mitsui F, Kono K, Ooi A. Kanta SY, et al. Hum Pathol. 2006 Oct;37(10):1333-43. doi: 10.1016/j.humpath.2006.05.008. Epub 2006 Aug 10. Hum Pathol. 2006. PMID: 16949920

3

HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.

Montironi R, Mazzucchelli R, Barbisan F, Stramazzotti D, Santinelli A, Scarpelli M, Lòpez Beltran A. Montironi R, et al. Hum Pathol. 2006 Sep;37(9):1137-44. doi: 10.1016/j.humpath.2006.04.004. Epub 2006 Jun 21. Hum Pathol. 2006. PMID: 16938518

4

Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.

Bouchalová K, Trojanec R, Kolár Z, Cwiertka K, Cernáková I, Mihál V, Hajdúch M. Bouchalová K, et al. Neoplasma. 2006;53(5):393-401. Neoplasma. 2006. PMID: 17013533

5

The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study.

Hicks DG, Yoder BJ, Pettay J, Swain E, Tarr S, Hartke M, Skacel M, Crowe JP, Budd GT, Tubbs RR. Hicks DG, et al. Hum Pathol. 2005 Apr;36(4):348-56. doi: 10.1016/j.humpath.2005.01.016. Hum Pathol. 2005. PMID: 15891995

6

Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer.

Konecny GE, Pauletti G, Untch M, Wang HJ, Möbus V, Kuhn W, Thomssen C, Harbeck N, Wang L, Apple S, Jänicke F, Slamon DJ. Konecny GE, et al. Breast Cancer Res Treat. 2010 Apr;120(2):481-9. doi: 10.1007/s10549-010-0744-z. Epub 2010 Feb 4. Breast Cancer Res Treat. 2010. PMID: 20130985

7

Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples.

Mueller RE, Parkes RK, Andrulis I, O'Malley FP. Mueller RE, et al. Genes Chromosomes Cancer. 2004 Apr;39(4):288-97. doi: 10.1002/gcc.20008. Genes Chromosomes Cancer. 2004. PMID: 14978790

8

Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.

Minner S, Jessen B, Stiedenroth L, Burandt E, Köllermann J, Mirlacher M, Erbersdobler A, Eichelberg C, Fisch M, Brümmendorf TH, Bokemeyer C, Simon R, Steuber T, Graefen M, Huland H, Sauter G, Schlomm T. Minner S, et al. Clin Cancer Res. 2010 Mar 1;16(5):1553-60. doi: 10.1158/1078-0432.CCR-09-2546. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179235

9

TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer.

Villman K, Sjöström J, Heikkilä R, Hultborn R, Malmström P, Bengtsson NO, Söderberg M, Saksela E, Blomqvist C. Villman K, et al. Acta Oncol. 2006;45(5):590-6. doi: 10.1080/02841860500543182. Acta Oncol. 2006. PMID: 16864174

10

A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment.

Hansel DE, Ashfaq R, Rahman A, Wanzer D, Yeo CJ, Wilentz RE, Maitra A. Hansel DE, et al. Am J Clin Pathol. 2005 Jan;123(1):28-35. Am J Clin Pathol. 2005. PMID: 15762277

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

261 results

Results by year